Ability Biologics
Giles Day is a skilled professional with a vast experience in the biotechnology industry. Having held various leadership roles in reputable companies such as Ability Biologics, Charles River Laboratories, Distributed Bio, and Pfizer Inc, Giles has a strong background in informatics and computational molecular biology. Graduating from The University of Manchester with a BSc/MSc in Computational Molecular Biology, Giles has consistently demonstrated his expertise and dedication throughout his career.
This person is not in any teams
This person is not in any offices
Ability Biologics
1 followers
Our Mission: Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases. The premier biotherapeutic targeting company Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics. We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need.